Ex Vivo Fluorescence Confirmation
Ex Vivo Fluorescence Confirmation - Related Videos
01:31
Confirmation Biases
0 Views •
2020
The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias? Another...
08:15
Tracking Dynamics of Muscle Engraftment in Small Animals by In Vivo Fluorescent Imaging
0 Views •
Cited by 4 •
2009
We describe an in vivo fluorescence imaging protocol to monitor muscle regeneration by GFP-labeled myoblasts after transplantation into skeletal muscles of both healthy and dystrophic mice. This protocol can be adapted to study muscle regeneration by transplantation of other types of cells and in other muscular conditions as well.
03:10
In Vivo Fluorescence Imaging to Localize Antibodies in a Mouse Tumor Xenograft Model
0 Views •
2025
The video demonstrates a fluorescence imaging method for in vivo antibody localization in a mouse tumor xenograft model. It involves the injection of tumor cells in a mouse to generate solid xenografts beneath the skin. Subsequent injection of fluorescent antibodies confirms specific localization through enhanced fluorescence signals within the tumor xenograft.
05:36
Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
0 Views •
Cited by 1 •
2024
We describe a fluorescent assay that can quickly and inexpensively confirm the ability of novel compounds to chelate iron. The assay measures the ability of compounds to outcompete the iron binding activity of the weak iron chelating fluorescent probe Calcein, resulting in a quantifiable increase in fluorescence when chelation occurs.
06:46
Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
0 Views •
Cited by 4 •
2017
This paper explains the application of fluorescent imaging using an activatable optical imaging probe to visualize the in vivo activity of key matrix metalloproteinases in two different experimental models of inflammation.
FAQs
Illuminating an excised specimen at the label's excitation wavelength activates the fluorescent signal so emitted light can be examined directly. This wavelength-specific step helps distinguish whether a detected signal is associated with the fluorescent label rather than inferred only from the original imaging observation. In cancer studies, it provides a direct check of signal presence in removed tissue.
Signal distribution shows where fluorescence appears across the excised tissue, while localization identifies its position in relation to the tissue being examined. Together, these observations help determine whether the pattern is consistent with the intended tumor-associated signal or biomarker labeling. They also provide tissue-level evidence for interpreting fluorescence-guided imaging findings.
By examining fluorescence in the removed tissue, researchers can compare the observed signal pattern with the biological target the label was intended to identify. A signal that is present in the relevant tissue and shows an interpretable distribution supports the labeling assessment. This makes specificity evaluation more evidence-based than relying on an in vivo signal alone.
An in vivo observation indicates that fluorescence was detected during imaging, but excised-tissue examination connects that observation to the tissue itself. This comparison can confirm signal presence and reveal its distribution and localization after removal. In cancer research, the added evidence strengthens conclusions about tissue targeting and the reliability of fluorescence-based imaging experiments.
After tissue removal, the fluorescently labeled tissue is illuminated at the label's excitation wavelength. Researchers then examine the emitted light for signal presence, distribution, and localization. The resulting observations are related back to the original imaging finding and the intended biological target. This workflow turns an imaging signal into a tissue-level validation assessment.
It is useful when studies need to assess tumor-associated signals, biomarker labeling, or findings from fluorescence-guided imaging. In each case, excised-tissue evidence helps determine whether the observed fluorescence corresponds to the intended biological target. The approach therefore supports interpretation of imaging experiments where tissue targeting, labeling specificity, and signal reliability are important outcomes.
A successful confirmation provides evidence that fluorescence observed during the experiment is also present in the excised tissue and can be examined for its spatial pattern. It supports assessment of labeling specificity and tissue targeting by grounding those evaluations in direct tissue evidence. These observations make conclusions about fluorescence-based findings more reliable.